Biopharmaceutics of Ocular Drug Delivery
The DOI matches its Crossref record.
Abstract
Anatomy and Physiology of the Eye. Physiological Aspects of Ocular Drug Therapy (Johan Stjernschantz and Maria Astin). Formulation of Ophthalmic Solutions and Suspensions. Problems and Advantages (Marc M.M. Van Ooteghem). The Effects of Preservatives on Corneal Permeability of Drugs (Keith Green). Solid Polymeric Inserts/Disks as Drug Delivery Devices (Marco Fabrizio Saettone). The Development and Use of In Situ Formed Gels, Triggered by pH (Robert Gurny, Houssam Ibrahim, and Pierre Buri). Liposomes and Nanoparticles as Ocular Drug Delivery Systems (Michael Mezei and Dale Meisner). Use of Hyaluronic Acid in Ocular Therapy (Stephanie R. Bernatchez, Ola Camber, Cyrus Tabatabay, and Robert Gurny). Improved Ocular Drug Delivery by Use of Chemical Modification (Prodrugs) (Vincent H. L. Lee). Bioadhesives in Ocular Drug Delivery (Eliot M. Slovin and Joseph R. Robinson). Pharmacokinetics in Ocular Drug Delivery (Ronald D. Schoenwald). Index. c. 224 pp., 7x10, due November 1992, ISBN 0-8493-7296-8.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Novel injectable neutral solutions of chitosan form biodegradable gels in situ
Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., Leroux, J. C., Atkinson, B. L., Binette, F., & Selmani, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00116-2 · Cited by 1,406
Chitosan: A Unique Polysaccharide for Drug Delivery
Felt, O., Buri, P., & Gurny, R. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809089942 · Cited by 769
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
MOTWANI, S., CHOPRA, S., TALEGAONKAR, S., KOHLI, K., AHMAD, F., & KHAR, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.09.009 · Cited by 557
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Recent advances in ocular drug delivery
Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335
Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system
Srividya, B., Cardoza, R. M., & Amin, P. D. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00279-6 · Cited by 330
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
Ammar, H. O., Salama, H. A., Ghorab, M., & Mahmoud, A. A. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9268-4 · Cited by 319
Ocular Preparations: The Formulation Approach
Pal Kaur, I., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Kaur, I. P., & Smitha, R. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002997 · Cited by 305
Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin
Liu, Z., Li, J., Nie, S., Liu, H., Ding, P., & Pan, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.029 · Cited by 276
Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., & Gurny, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00164-6 · Cited by 268
Factors affecting microencapsulation of drugs in liposomes
Kulkarni, S. B., Betageri, G. V., & Singh, M. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509010292 · Cited by 261
Advances in ophthalmic drug delivery
Morrison, P. W., & Khutoryanskiy, V. V. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.75 · Cited by 196
Metadata
- Authors
- Edman, P.
- Venue
- CRC Press eBooks
- Publisher
- CRC Press
- Published
- 2019-08-15
- OpenAlex
- W566714375
- Cited by
- 160
- References
- 0
- FWCI
- 1.09
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.